T. Rowe Price Investment Management, Inc. Cytokinetics Inc Call Options Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
394Shares Held
126MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$516 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$416 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$281 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$214 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.07MShares$108 Million4.32% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.31B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...